Letting Science Drive Technology at GlaxoSmithKline

Explore how GlaxoSmithKline leverages Docker to revolutionize their drug discovery process in this 32-minute conference talk. Discover how the global healthcare company optimizes its R&D efforts by implementing 'edge nodes on demand,' streamlining cluster management, and significantly reducing software deployment time. Learn about the challenges faced in managing multiple Hadoop clusters and niche open-source software adoptions, and how Docker provides solutions to these issues. Gain insights into GSK's Data Lifecycle, R&D Information Platform, and the architecture behind their Edge Node On Demand system. Understand the key values and opportunities presented by this innovative approach, which allows scientists to seamlessly transition between clusters while maintaining their work environment intact.

Intro
Science leading technology
Drug discovery is tough...
Biology is complicated
Data Lifecycle at GSK
The opportunity
R&D Information Platform
Platform Summary
Why Edge Node On Demand?
What is "Edge Node on Demand"?
Architecture - ENOD
ENOD Demo Scenario
Key Value Highlights
Docker Powers......
Opportunities Faced along the
Acknowledgements